Цена покупки
25,33
25,33
25,32
233.06 B
Показатели за предыдущие периоды не являются гарантией будущих результатов.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Создайте счет и пройдите быструю верификацию.
Пополните свой кошелек с помощью карты, банковского перевода или криптовалюты.
Выберите PFE, установите сумму и нажмите купить или продать — вот и все!
Pfizer Inc.
PFE
25,325
+0.68%
FAQ